Skip to main content
Caplight Logo









Blue Practice株式会社

Blue Practice株式会社

Private
TokyoHealthcare & Life Scienceshttps://bluepractice.co.jp/

Last Round

Debt

Jan 20, 2025

Est. Valuation

$4.6M

Total Funding Raised

$191,000

Company Overview

Blue Practice株式会社 is a medical technology company that develops and provides high-fidelity artificial blood vessel models and simulation platforms for surgical training and medical device testing.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Hardware + Subscription

AI Layer

Application

Keywords

vascular modelssurgical simulationanatomical modelsmedical device evaluationpatient-specific modelssurgical trainingorgan replicaPVA hydrogeltissue phantompre-operative planningsynthetic tissuecatheter simulationanimal model alternatives3D printed organsneurovascular simulationmedical simulation platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Blue Practice株式会社 Comparables

Compare Blue Practice株式会社 with similar companies based on industry and business-model similarity.

Blue Practice株式会社 comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SurgeonsLab AG
82%
LifeLike BioTissue Inc.
81%
SynDaver
69%

Blue Practice株式会社 Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtJan 20, 2025
Series AApr 19, 2023
VC RoundAug 28, 2020

Blue Practice株式会社 Investors

Notable investors and investment history

Blue Practice株式会社 investors
InvestorRounds
Tohoku University Venture PartnersVC Round
The 77 Bank, Ltd.Debt

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 20, 2025

    $191K round from The 77 Bank, Ltd.

  • Apr 19, 2023

    Closed Series A round with a post-money valuation of $4.6M.

Blue Practice株式会社 Filings

Explore SEC and related filing metadata, where available.

Blue Practice株式会社 filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Blue Practice株式会社's valuation, stock price, and market status.

Is Blue Practice株式会社 a public or private company?

Blue Practice株式会社 is a private company.

What is the current stock price of Blue Practice株式会社?

Blue Practice株式会社 is a private company with no public stock price. No recent secondary market data is available.

How much is Blue Practice株式会社 worth (valuation)?

Blue Practice株式会社's valuation is estimated at $4.6M based on funding round data.

Can I buy Blue Practice株式会社 stock?

Blue Practice株式会社 shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Blue Practice株式会社's last funding round?

Blue Practice株式会社's most recent funding round was Debt on April 19, 2023.

Who are the main investors in Blue Practice株式会社?

Key investors in Blue Practice株式会社 include Tohoku University Venture Partners, The 77 Bank, Ltd..

Will Blue Practice株式会社 IPO soon?

No public IPO plans have been announced for Blue Practice株式会社.

How can I track Blue Practice株式会社 secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Blue Practice株式会社's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTokyo
Year Founded2019
Last FundingJan 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?